Dehydrozingerone, a Curcumin Analog, as a Potential Anti-Prostate Cancer Inhibitor in Vitro and in Vivo
© 2020 MDPI AG. All rights reserved. Curcumin (Cur) exhibits biological activities that support its candidacy for cancer treatment. However, there are limitations to its pharmacological effects, such as poor solubility and bioavailability. Notably, the use of Cur analogs has potential for addressing...
Saved in:
Main Authors: | Sariya Mapoung, Shugo Suzuki, Satoshi Fuji, Aya Naiki-Ito, Hiroyuki Kato, Supachai Yodkeeree, Natee Sakorn, Chitchamai Ovatlarnporn, Satoru Takahashi, Pornngarm Limtrakul |
---|---|
Format: | Journal |
Published: |
2020
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85086687135&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/70226 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Cyclohexanone curcumin analogs inhibit the progression of castration-resistant prostate cancer in vitro and in vivo
by: Sariya Mapoung, et al.
Published: (2019) -
Chemosensitizing effects of synthetic curcumin analogs on human multi-drug resistance leukemic cells
by: Sariya Mapoung, et al.
Published: (2018) -
Chemosensitizing effects of synthetic curcumin analogs on human multi-drug resistance leukemic cells
by: Mapoung S., et al.
Published: (2017) -
Curcumin as chemosensitizer
by: Pornngarm Limtrakul
Published: (2018) -
Curcumin, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and uPA
by: Supachai Yodkeeree, et al.
Published: (2018)